Enanta Pharmaceuticals (NASDAQ:ENTA) Upgraded by Wall Street Zen to “Hold” Rating
Enanta Pharmaceuticals (NASDAQ:ENTA – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued to investors on Sunday. Separately, JMP Securities boosted their price target on Enanta Pharmaceuticals from $23.00 to $24.00 and gave the company a “market outperform” […]
Enanta Pharmaceuticals (NASDAQ:ENTA – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued to investors on Sunday. Separately, JMP Securities boosted their price target on Enanta Pharmaceuticals from $23.00 to $24.00 and gave the company a “market outperform” […]
